Call Us Free: (800) 394-2767

Bay Area biotech unicorn suffers 5th worst Wall Street debut of year


Shares of Vir Biotechnology Inc. dropped 29.9 percent in their first day of trading on Friday, marking the fifth worst Wall Street debut this year.

The only ones with bigger first-day drops than the San Francisco biotech in 2019, according to IPO research firm Renaissance Capital, have been:

Chinese e-commerce business Ruhnn Holding Ltd. (down 37.2 percent).
Chinese athletic event company Wanda Sports Group Co. Ltd. (down 35.5 percent).
Canadian cannabis company Sundial Growers Inc. (down 34.8…


Source link